Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Promoting excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Alexandros Patrianakos
View the Slides from this session in ESC Congress 365
In this interesting session, Dr Pedro Guitierrez- Fajardo (Guadalajara, MX) discussed the usefulness of 3D echo today. He believes that 3D echo is very useful in the assessment of Left Ventricular (LV) volumes and function as it appears to have less variability than 2D echo and a close relationship with MRI.Additionally, he suggests that the estimation of LV synchrony, especially with 3D speckle tracking echocardiography may become a promising tool.He noted that with a 3D model it is possible to evaluate the right ventricle size and function, which will help many patients in the near future.
Cristian Lopez (Santiago, CL) discussed the use of multi-slice CT in cardiology. He focused on coronary angiography (CTA) in symptomatic patients with negative stress tests and uncertain chest pain origin. He also talked about the contribution of CTA in the examination of coronary anatomy, plaque characterization and congenital coronary anomalies. He noted the possible use of Cardiac CT in the evaluation of cardiac anatomy function and in the recognition of cardiac masses.
Sophie Mavrogeni (Athens, GR) focused on how to use cardiac MRI (CMR) as a pathophysiology tool in the assessment of myocardial inflammation, fibrosis, acuity of heart involvement, tissue characterization and great vessel pathophysiology. She also discussed how the developmental evolution of CMR can be incorporated into practice.She supports the CMR use in coronary artery disease for the recognition of silent myocardial infarction, late gadolinium enhancement (LGE) extent, perfusion defects and atheromatous plaque characterization. In myocarditis, she says that early GE and LGE had the best correlation for the development of Heart Failure.Dr. Mavrogeni emphasized the detection of cardiac involvement with CMR in other internal diseases, such as in hematology (thalasemia, iron overloaded diseases, etc.) in rheumatology (like rheumatic arthritis lupus systemic sclerosis, etc ) in endocrinology and in oncology. Finally, she mentioned a possible future role of interventional CMR in pediatrics and in electrophysiology.
Eduardo Casas Rojo (Madrid, ES) discussed fusion imaging in cardiology. Starting with fusion imaging with PET/SPECT+ CT software (radiation imaging) he moved on to discuss newer fusion with 3D- speckle imaging and cardiac CT at rest, or stress for ischemia detection. Additionally, he noted a different application of hybrid images: the echo navigator. With echo navigator, echo goes into the catherization laboratory and synchronizes fluoroscopy and real-time 3D echo and helps guide interventional techniques, like foramen ovale closure, TAVI, or periprosthetic leaks closure.
Cardiovascular imaging: a logistic and futuristic approach, ESC and the Interamerican Society of Cardiology